Guardant Health Inc (GH)

Currency in USD
53.32
+2.93(+5.80%)
Real-time Data·
GH Scorecard
Full Analysis
Significant return over the last week
Trading near 52-week High
GH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
51.4453.79
52 wk Range
20.1453.79
Key Statistics
Prev. Close
50.39
Open
52
Day's Range
51.44-53.79
52 wk Range
20.14-53.79
Volume
1.62M
Average Volume (3m)
2.33M
1-Year Change
48.38%
Book Value / Share
-2.47
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
61.27
Upside
+14.92%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Guardant Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Guardant Health Inc Company Profile

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-powered PD-L1 detection; GuardantINFINITY Test that provides insights into the complexities of tumor molecular profiles and immune response to advance cancer research and therapy development; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI blood test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for adjuvant treatment and surveillance settings in early-stage cancer patients; and Smart Liquid Biopsy Platform. In addition, the company provides development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kit fulfillment and delivery of Shield screening tests. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Guardant Health Inc Earnings Call Summary for Q2/2025

  • Q2 2025 revenue grew 31% YoY to $232.1M, beating forecasts; EPS of -$0.44 surpassed -$0.72 estimate
  • Stock rose 4.32% after-hours; company launched 11 new smart liquid biopsy applications
  • Full-year revenue guidance raised to $915-$925M; Shield revenue guidance increased to $55-$60M
  • Company aims for cash flow breakeven by 2028; maintains strong liquidity with current ratio of 4.11
  • Executives confident in financial trajectory; emphasize strategic importance of innovations in oncology
Last Updated: 30/07/2025, 23:34
Read Full Transcript

Compare GH to Peers and Sector

Metrics to compare
GH
Peers
Sector
Relationship
P/E Ratio
−15.2x−1.1x−0.5x
PEG Ratio
−0.840.010.00
Price/Book
−20.6x1.7x2.6x
Price / LTM Sales
7.6x1.0x3.3x
Upside (Analyst Target)
19.1%50.1%43.4%
Fair Value Upside
Unlock17.4%7.1%Unlock

Analyst Ratings

22 Buy
2 Hold
0 Sell
Ratings:
24 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 61.27
(+14.92% Upside)

Earnings

Latest Release
Jul 30, 2025
EPS / Forecast
-0.44 / -0.72
Revenue / Forecast
232.10M / 211.27M
EPS Revisions
Last 90 days

GH Income Statement

People Also Watch

159.65
CRCL
+4.39%
250.41
AVAV
-3.55%
65.20
KTOS
+10.36%
17.72
BEAM
-0.81%
73.93
MP
+4.02%

FAQ

What Stock Exchange Does Guardant Health Trade On?

Guardant Health is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Guardant Health?

The stock symbol for Guardant Health is "GH."

What Is the Guardant Health Market Cap?

As of today, Guardant Health market cap is 6.65B.

What Is Guardant Health's Earnings Per Share (TTM)?

The Guardant Health EPS (TTM) is -3.35.

When Is the Next Guardant Health Earnings Date?

Guardant Health will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is GH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Guardant Health Stock Split?

Guardant Health has split 0 times.

How Many Employees Does Guardant Health Have?

Guardant Health has 2010 employees.

What is the current trading status of Guardant Health (GH)?

As of 08 Aug 2025, Guardant Health (GH) is trading at a price of 53.32, with a previous close of 50.39. The stock has fluctuated within a day range of 51.44 to 53.79, while its 52-week range spans from 20.14 to 53.79.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.